Professional Documents
Culture Documents
ФГБУ «Научный центр экспертизы средств медицинского применения» Минздрава России, Москва
Îáåñïå÷åíèå êà÷åñòâà, áåçîïàñíîñòè è ýôôåêòèâíîñòè ëåêàðñòâåííûõ ïðåïàðàòîâ, ïîñòóïàþùèõ â îáîðîò Ðîññèè, ÿâëÿ-
åòñÿ îäíèì èç ïðèîðèòåòíûõ íàïðàâëåíèé, òðåáóþùèõ ãîñóäàðñòâåííîãî êîíòðîëÿ è íàäçîðà. Ïðè èçìåíåíèè òåõíîëîãèè
ïðîèçâîäñòâà áèîëîãè÷åñêèõ ëåêàðñòâåííûõ ïðåïàðàòîâ âîçíèêàåò íåîáõîäèìîñòü ïîäòâåðæäåíèÿ îòñóòñòâèÿ âëèÿíèÿ íà
áåçîïàñíîñòü è ýôôåêòèâíîñòü, âûðàæàþùåãîñÿ â ñîïîñòàâèìîñòè ïðåïàðàòîâ äî è ïîñëå èçìåíåíèÿ. Â ñâÿçè ñ îòñóòñòâè-
åì íåîáõîäèìîãî ïðàâîâîãî ðåãóëèðîâàíèÿ êàê íèêîãäà àêòóàëüíà íåîáõîäèìîñòü ãàðìîíèçàöèè ñóùåñòâóþùåãî ðîññèé-
ñêîãî çàêîíîäàòåëüñòâà, ïîäõîäîâ ê ïðåä- è ïîñòðåãèñòðàöèîííîé ðàçðàáîòêå è ýêñïåðòèçå áèîëîãè÷åñêèõ ëåêàðñòâåííûõ
ïðåïàðàòîâ ñ ìåæäóíàðîäíûì îïûòîì îáåñïå÷åíèÿ èõ êà÷åñòâà, áåçîïàñíîñòè è ýôôåêòèâíîñòè.
Ensuring quality, safety and efficacy of the medicinal products placed on the market of the Russian Federation constitutes the area
that requires strict regulation. When changes are made to the manufacturing process, the manufacturer generally needs to evaluate
the relevant quality attributes of the product to demonstrate that modifications did not occur that would adversely impact the safety
and efficacy of the drug. Where there is the lack of a sound legal basis, there is a need in harmonization of current Russian legisla-
tion with international and European rules governing medicinal product for human use to ensure quality, safety and efficacy thereof.
Key words: biological medicinal products, comparability, pre-clinical and clinical trials, manufacturing process, changes in manu-
facturing process, biosimilars.
Èçìåíåíèÿ ïðîöåññà  öåëÿõ ïîäòâåðæäåíèÿ, ÷òî èìåþùèåñÿ äîêëèíè÷åñêèå è êëèíè÷åñêèå äàííûå, ïîëó÷åííûå
ïðîèçâîäñòâà äî íà÷àëà äî èçìåíåíèÿ, îñòàþòñÿ äåéñòâèòåëüíûìè è âîçìîæíà èõ ýêñòðàïîëÿöèÿ íà èçìåí¸ííûé
ïîäòâåðæäàþùèõ ëåêàðñòâåííûé ïðåïàðàò, êàê ïðàâèëî, äîñòàòî÷íî ïðåäñòàâèòü ñîîòâåòñòâóþùèå ðåçóëüòàòû
èññëåäîâàíèé ôèçèêî-õèìè÷åñêèõ è áèîëîãè÷åñêèõ (in vivo è in vitro) è, â íåêîòîðûõ ñëó÷àÿõ, òàêæå
äîêëèíè÷åñêèõ èëè êëèíè÷åñêèõ èññëåäîâàíèé ñîïîñòàâèìîñòè, íàïðèìåð,
ôàðìàêîêèíåòè÷åñêîãî èññëåäîâàíèÿ ñ îäíîêðàòíûì ââåäåíèåì.
Èçìåíåíèÿ ïðîöåññà Íå ðåêîìåíäóåòñÿ îñóùåñòâëÿòü èçìåíåíèÿ â õîäå ïîäòâåðæäàþùåãî èññëåäîâàíèÿ;
ïðîèçâîäñòâà â õîäå â ïðîòèâíîì ñëó÷àå çàÿâèòåëþ ñëåäóåò îáðàòèòüñÿ çà íàó÷íîé êîíñóëüòàöèåé.
ïîäòâåðæäàþùèõ
êëèíè÷åñêèõ
èññëåäîâàíèé
Èçìåíåíèÿ ïðîöåññà Åñëè èçìåíåíèå ïðîèçâîäñòâà ïðîèñõîäèò ïî çàâåðøåíèè ïîäòâåðæäàþùåãî(èõ) èññëåäîâàíèÿ(é)
ïðîèçâîäñòâà èëè ïîñëå ãîñóäàðñòâåííîé ðåãèñòðàöèè, êàê ïðàâèëî, òðåáóþòñÿ áîëåå ãëóáîêèå èññëåäîâàíèÿ
ïî çàâåðøåíèè ñîïîñòàâèìîñòè, âêëþ÷àÿ ôèçèêî-õèìè÷åñêèå è áèîëîãè÷åñêèå èññëåäîâàíèÿ in vitro è, âîçìîæíî,
ïîäòâåðæäàþùèõ êëèíè÷åñêèå ôàðìàêîêèíåòè÷åñêèå è (èëè) ôàðìàêîäèíàìè÷åñêèå èññëåäîâàíèÿ ñîïîñòàâèìîñòè.
èññëåäîâàíèé Åñëè ðåçóëüòàòû òàêèõ èññëåäîâàíèé ñîïîñòàâèìîñòè íå èñêëþ÷àþò âëèÿíèÿ íà ïðîôèëü
èëè ïîñëå ýôôåêòèâíîñòè è áåçîïàñíîñòè ëåêàðñòâåííîãî ïðåïàðàòà, ìîæåò(ãóò) ïîòðåáîâàòüñÿ
ãîñóäàðñòâåííîé äîïîëíèòåëüíîå(ûå) êëèíè÷åñêîå(èå) èññëåäîâàíèå(ÿ).
ðåãèñòðàöèè